Sirjiwan Singh

Biography

Sirjiwan became a part of Wockhardt during the acquisition of Merind in 1998 and was actively involved in the post-acquisition, integration and rationalisation with the parent Company. After the acquisition of C P Pharmaceuticals Ltd. he was posted in UK as Managing Director of Wockhardt UK Limited, combined entity established from the integration of C P Pharmaceuticals and Wallis Laboratories in the United Kingdom. Since 2003 he has played a key role in restructuring the product portfolio and and expanding the business in the the UK. As Managing Director of Wockhardt UK, he is responsible for growing the business in these regions through strategic implementations of business initiatives across the sales, marketing, manufacturing and operation functions. Sirjiwan Singh has built a robust business for these regions by exploring alliances ,tapping new business opportunities and optimising the operations of the manufacturing facility in UK. He has also played a major role in due diligence , acquisitions and integrations of various companies into the Wockhardt Group.

Research Interest

Bioinformatics and system biology